Literature DB >> 15809895

Pharmacogenomics and HIV therapeutics.

David W Haas.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15809895     DOI: 10.1086/429303

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

Review 1.  Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors:  Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

2.  Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.

Authors:  Qing Ma; Barry S Zingman; Amneris E Luque; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Robin DiFrancesco; Alan Forrest; Gene D Morse
Journal:  Ther Drug Monit       Date:  2011-06       Impact factor: 3.681

3.  Treatment of pediatric HIV infection.

Authors:  Elisa A d'Oulx; Elena Chiappini; Maurizio de Martino; Pier-Angelo Tovo
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

Review 4.  Nucleoside and nucleotide reverse transcriptase inhibitors in children.

Authors:  Carlo Giaquinto; Osvalda Rampon; Martina Penazzato; Federica Fregonese; Anita De Rossi; Ruggiero D'Elia
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

5.  Effect of HIV-1 infection on human DNA yield from saliva.

Authors:  Rebecca J Basham; Danielle M Richardson; Cara B Sutcliffe; David W Haas
Journal:  HIV Clin Trials       Date:  2009 Jul-Aug

6.  Nevirapine plasma concentrations are associated with virologic response and hepatotoxicity in Chinese patients with HIV infection.

Authors:  Jia Wang; Huijuan Kou; Qiang Fu; Yang Han; Zhifeng Qiu; Lingyan Zuo; Yanling Li; Zhu Zhu; Min Ye; Qing Ma; Taisheng Li
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

7.  [Treatment failure in children infected with HIV in routine follow-up in a resource-limited setting in Cameroon].

Authors:  Calixte Ida Penda; Francine Same Bebey; Danielle Kedy Mangamba; Else Carole Eboumbou Moukoko; Victoria Ngwa; Nicaise Makouet; Anne-Cécile Bissek; Blaise Dupont Minkemdefo; Ekoe Tetanye; Paul Koki Ndombo
Journal:  Pan Afr Med J       Date:  2013-06-30

8.  Effects of CYP2B6 polymorphisms on plasma nevirapine concentrations: a systematic review and meta-analysis.

Authors:  Ha Young Yoon; Young Ah Cho; Jeong Yee; Hye Sun Gwak
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

9.  Predictors of disease progression in HIV infection: a review.

Authors:  Simone E Langford; Jintanat Ananworanich; David A Cooper
Journal:  AIDS Res Ther       Date:  2007-05-14       Impact factor: 2.250

10.  The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand.

Authors:  Asalaysa Bushyakanist; Apichaya Puangpetch; Chonlaphat Sukasem; Sasisopin Kiertiburanakul
Journal:  Pharmgenomics Pers Med       Date:  2015-11-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.